3-(bromomethyl)-4-chloropyridine | 1227606-10-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-(bromomethyl)-4-chloropyridine
• CAS: 1227606-10-1
• 化学式: C₆H₅BrClN
• 分子量: 206.469
• InChiKey: LQPSTIJNSDWPLK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-(bromomethyl)-4-chloropyridine 、 三苯基膦 以 甲苯 为溶剂， 反应 144.0h， 以1.2 g的产率得到[(2-chloropyridine-3-yl)methyl](triphenyl)phosphonium bromide
  参考文献：
  名称：

  Double Palladium-Catalyzed Synthesis of Azepines

  摘要：

  The synthesis of new 5H-pyridobenzazepine and 5H-dipyridoazepine compounds using as key step a palladium-catalyzed amination-cyclization reaction is reported. By choosing an appropriate combination of ligands and reactants under standardized reaction conditions, N- and S-tricyclic products can be prepared in one step from the appropriate stilbenes.

  DOI：

  10.1055/s-0032-1317667
• 作为产物：
  描述：

  4-氯吡啶盐酸盐 在 sodium tetrahydroborate 、 正丁基锂 、 三溴化磷 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 甲醇 、 正己烷 、 二氯甲烷 为溶剂， 反应 5.5h， 生成 3-(bromomethyl)-4-chloropyridine
  参考文献：
  名称：

  Double Palladium-Catalyzed Synthesis of Azepines

  摘要：

  The synthesis of new 5H-pyridobenzazepine and 5H-dipyridoazepine compounds using as key step a palladium-catalyzed amination-cyclization reaction is reported. By choosing an appropriate combination of ligands and reactants under standardized reaction conditions, N- and S-tricyclic products can be prepared in one step from the appropriate stilbenes.

  DOI：

  10.1055/s-0032-1317667

文献信息

• 6H-THIENO[2,3-E][1,2,4]TRIAZOLO[3,4-C][1,2,4]TRIAZEPINE DERIVATIVE
  申请人：AYUMI Pharmaceutical Corporation

  公开号：EP3640253A1

  公开（公告）日：2020-04-22

  The 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivatives or salts thereof of the present invention have BRD4 inhibitory activity, and thus, they are useful as medicaments, in particular, as prophylaxis and/or therapeutic agents for diseases associated with BRD4.

  本发明的 6H-噻吩并[2,3-e][1,2,4]三唑并[3,4-c][1,2,4]三氮杂卓衍生物或其盐类具有 BRD4 抑制活性，因此可用作药物，特别是用作与 BRD4 相关疾病的预防和/或治疗药物。
• Indazolones as modulators of tnf signaling
  申请人：AbbVie Inc.

  公开号：US10160748B2

  公开（公告）日：2018-12-25

  The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.

  本公开提供了吲唑酮化合物、药学上可接受的盐、原药、生物活性代谢物、立体异构体和异构体，其中变量在本文中定义。本公开的化合物可用于治疗免疫学和肿瘤学疾病。
• 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative
  申请人：AYUMI PHARMACEUTICAL CORPORATION

  公开号：US11186588B2

  公开（公告）日：2021-11-30

  The 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivatives or salts thereof of the present invention have BRD4 inhibitory activity, and thus, they are useful as medicaments, in particular, as prophylaxis and/or therapeutic agents for diseases associated with BRD4.

  本发明的 6H-噻吩并[2,3-e][1,2,4]三唑并[3,4-c][1,2,4]三氮杂卓衍生物或其盐类具有 BRD4 抑制活性，因此可用作药物，特别是用作与 BRD4 相关疾病的预防和/或治疗药物。
• INDAZOLONES AS MODULATORS OF TNF SIGNALING
  申请人：AbbVie Inc.

  公开号：US20160304496A1

  公开（公告）日：2016-10-20

  The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.
• 6H-THIENO[2,3-e][1,2,4]TRIAZOLO[3,4-c][1,2,4]TRIAZEPINE DERIVATIVE
  申请人：AYUMI PHARMACEUTICAL CORPORATION

  公开号：US20210130367A1

  公开（公告）日：2021-05-06

  The 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivatives or salts thereof of the present invention have BRD4 inhibitory activity, and thus, they are useful as medicaments, in particular, as prophylaxis and/or therapeutic agents for diseases associated with BRD4.